Category: Disease Prevention & Management

The field of neuroendocrinology is witnessing a transformative shift as researchers move beyond traditional genetic sequencing toward functional disease modeling using induced pluripotent stem cells (iPSCs). At the forefront of this evolution in South America is Dr. Maria Andrea Camilletti, an assistant researcher at the Laboratory of Applied Research in Neurosciences (LIAN) within the Institute…

In a decisive move that highlights the intersection of clinical excellence and groundbreaking basic science, the membership of the Endocrine Society has elected Joy Wu, MD, PhD, of the Stanford University School of Medicine, to serve as the organization’s President for the 2027–2028 term. Dr. Wu, a renowned figure in the fields of bone health…

The Endocrine Society has officially announced that Rebecca Reynolds, MD, PhD, has been selected as the recipient of the 2026 International Excellence in Endocrinology Laureate Award, a distinction that recognizes her pioneering contributions to the field of metabolic medicine and her profound impact on global maternal-fetal health. Dr. Reynolds, who serves as the Personal Chair…

The city of Chicago is finalized as the host destination for ENDO 2026, the premier global gathering for endocrine research and clinical practice, scheduled to take place from June 13 to June 16, 2026. This annual meeting, organized by the Endocrine Society, will convene at McCormick Place West, one of the largest convention facilities in…

Recent scientific evidence published in the Journal of the Endocrine Society has unveiled a significant link between paternal nicotine consumption and the metabolic health of future generations. The study, led by researchers at the University of California, Santa Cruz (UCSC), demonstrates that a father’s exposure to nicotine can fundamentally alter the way his offspring process…

Eli Lilly and Company has announced that its experimental once-daily oral medication, orforglipron, has successfully met all primary and secondary endpoints in two pivotal Phase 3 clinical trials, ACHIEVE-2 and ACHIEVE-5. The data, released in October 2025, suggest that the small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist provides superior glycemic control and weight reduction compared to…

A comprehensive retrospective cohort study has established a definitive link between even minor elevations in maternal blood sugar during pregnancy and an increased risk of obesity in children as they transition into adolescence. Published in the prestigious Journal of Clinical Endocrinology & Metabolism, the research indicates that the metabolic environment of the womb serves as…

The Pershing Square Foundation has officially announced that Dr. Daniel Hochbaum, a distinguished member of the Endocrine Society and an assistant professor at Harvard Medical School, is a recipient of the prestigious Maximizing Innovation in Neurodegenerative Diseases (MIND) Prize. This significant accolade includes a three-year grant totaling $750,000, specifically designated to accelerate Dr. Hochbaum’s pioneering…

The Endocrine Society’s recent virtual Science Writers Conference has signaled a transformative era in the treatment of obesity, transitioning the clinical focus from mere weight reduction to a broader paradigm of metabolic health through the advancement of glucagon-like peptide-1 (GLP-1) receptor agonists and multi-receptor therapies. During the event, leading endocrinology experts Priya Jaisinghani, MD, DABOM,…

In a strategic move to bolster its leadership in metabolic research and clinical care, NYU Langone Health has named Marcus D. Goncalves, MD, PhD, as the new director of the Holman Division of Endocrinology, Diabetes, and Metabolism. Dr. Goncalves, a distinguished physician-scientist with a focus on the intersection of systemic metabolism and oncology, succeeds Ira…